Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaos Svoronos

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|December 17, 2013
Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancerAmelia J Tesone, Nikolaos Svoronos, Michael J Allegrezza, et al.
Advances in Cancer Research|July 29, 2015
The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsMelanie R Rutkowski, Nikolaos Svoronos, Alfredo Perales-Puchalt, et al.
Frontiers in Immunology|December 8, 2025
Disruption of Notch signaling by KGF induces a developmental pause in thymocytesRuifeng Teng, Francis A Flomerfelt, Ping Xue, et al.
Vaccine|April 19, 2015
Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge modelDaniel O Villarreal, Nikolaos Svoronos, Megan C Wise, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Cell Reports|September 15, 2016
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 ExpressionHengrui Zhu, Fee Bengsch, Nikolaos Svoronos, et al.
Oncoimmunology|December 15, 2018
IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironmentAlfredo Perales-Puchalt, Nikolaos Svoronos, Daniel O Villarreal, et al.
Cancer Research|November 3, 2016
Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological MyelopoiesisMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Immunity|September 20, 2014
Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expressionTom L Stephen, Melanie R Rutkowski, Michael J Allegrezza, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancerMelanie R Rutkowski, Michael J Allegrezza, Nikolaos Svoronos, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|December 17, 2013
Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancerAmelia J Tesone, Nikolaos Svoronos, Michael J Allegrezza, et al.
Advances in Cancer Research|July 29, 2015
The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsMelanie R Rutkowski, Nikolaos Svoronos, Alfredo Perales-Puchalt, et al.
Frontiers in Immunology|December 8, 2025
Disruption of Notch signaling by KGF induces a developmental pause in thymocytesRuifeng Teng, Francis A Flomerfelt, Ping Xue, et al.
Vaccine|April 19, 2015
Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge modelDaniel O Villarreal, Nikolaos Svoronos, Megan C Wise, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Cell Reports|September 15, 2016
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 ExpressionHengrui Zhu, Fee Bengsch, Nikolaos Svoronos, et al.
Oncoimmunology|December 15, 2018
IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironmentAlfredo Perales-Puchalt, Nikolaos Svoronos, Daniel O Villarreal, et al.
Cancer Research|November 3, 2016
Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological MyelopoiesisMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Immunity|September 20, 2014
Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expressionTom L Stephen, Melanie R Rutkowski, Michael J Allegrezza, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancerMelanie R Rutkowski, Michael J Allegrezza, Nikolaos Svoronos, et al.
Pageof 2